Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

NCT05318469 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Triple-Negative Breast Carcinoma

Interventions

DRUG: Ivermectin
DRUG: Balstilmab
DRUG: Pembrolizumab

Sponsor

Yuan Yuan

Collaborators

[object Object]
[object Object]